ONLINE SPARK-BIH Entrepreneurial Forum | Prof. Dr. Franz Theuring "Developing a Tau-Based Drug to Fight Alzheimer's Disease: A Long and Winding Road in the Land of Amyloid"

Planning to Found a Life Science Company?

The transition from an academic research project to an established medical solution is a long and labor intensive process that can fail at various steps. What are the main challenges and common pitfalls that occur? What are the crucial steps to keep in mind?

In the Online Entrepreneurial Forum "Developing a Tau-Based Drug to Fight Alzheimer's Disease: A Long and Winding Road in the Land of Amyloid", Prof. Dr. Franz Theuring, Professor for Pharmacology and Toxicology at the Charité and Co-Founder of TauRx Therapeutics, will tell us about his experience of working in pharmaceutical industry and founding a pharmaceutical company.

After the online lecture of this very specific example you will have insight in some aspects of the

  • process of founding a pharmaceutical company
  • collaboration of academia and industry
  • challenges occurring when transitioning from academia to industry
     

Lecture Series

We currently offer two public Lecture Series, which alternate each month:

The SPARK-BIH Educational Forum is designed to teach academic scholars the principles of Drug, Device & Diagnostic Development with focus on topics which are relevant for translational medicine.

In our SPARK-BIH Entrepreneurial Forum we recruit key opinion leaders in the fields of Business Planning & Development, Financing and Commercialization to teach entrepreneurial scientists.
 

About SPARK-BIH

SPARK-BIH is a mentoring program that supports academic inventions with education, mentorship and funding. The program is designed to de-risk projects with high potential impact, addressing critical unmet medical needs for any indication. Our aim is to accelerate the translation of academic inventions into outstanding medical products including drugs, diagnostics and medical devices.